Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Wisp vs Woodwork

Wisp
Graded #59

Higher grade

vs+2
Woodwork
Graded #73

Lower grade

The verdict

Wisp takes it — 75/100 to 73/100, but only just.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month. Woodwork is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWisp +6
83
77
Dose & formulationWisp +13
88
75
Clinical oversightEven
82
82
Labs & monitoringWoodwork +21
53
74
FulfillmentEven
66
66
Contract termsWisp +14
55
41
Wisp · left barWoodwork · right bar

The numbers

MetricWispWoodwork
WeighScore75/10073/100
GradeCC
Scorecard rank#59#73
Semaglutide$225/mo (compounded oral)$127/mo (starting dose, compounded)
Tirzepatide$99/mo (starting dose, brand-name)$199/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesYes
Wisp

Graded #59 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
  • Pharmacy partners not named
  • States served not listed publicly
Woodwork

Graded #73 · C

Strengths

  • Low transparent pricing: compounded semaglutide from $127/month, tirzepatide from $199/month, microdose $134/month
  • Compounded semaglutide offered as injection or oral tablet
  • No separate consult or membership fees
  • Free shipping, included lab work, and 1-on-1 care coaching
  • HSA and FSA eligible; bundles a free Grindr Unlimited subscription

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Cash-pay only — no insurance billing
  • States served are not listed publicly
  • No compounding pharmacy partner named and no LegitScript badge shown
  • Weight loss is secondary to the platform's men's-health/ED focus

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard